Camlin Fine Sciences Ltd

Camlin Fine Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Camlin Fine Sciences Ltd

₹ 120 0.68%
22 Nov - close price
camlinfs.com BSE: 532834 NSE: CAMLINFINE
About

Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.

Key Points

Business Verticals

Website BSE NSE
  • Market Cap ₹ 2,010 Cr.
  • Current Price ₹ 120
  • High / Low ₹ 143 / 80.0
  • Stock P/E
  • Book Value ₹ 37.6
  • Dividend Yield 0.00 %
  • ROCE 0.37 %
  • ROE -7.23 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 3.19 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 7.12% over past five years.
  • Company has a low return on equity of 1.36% over last 3 years.
  • Company has high debtors of 232 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
138 200 201 155 243 173 218 161 206 186 220 182 227
135 177 170 140 201 145 184 136 185 180 246 175 213
Operating Profit 3 23 31 15 42 28 34 25 21 6 -26 7 14
OPM % 2% 12% 16% 10% 17% 16% 16% 16% 10% 3% -12% 4% 6%
1 7 8 13 12 11 1 6 6 2 4 2 -93
Interest 7 6 10 16 16 12 13 12 15 13 14 14 18
Depreciation 7 7 7 7 7 8 11 12 12 12 13 13 13
Profit before tax -10 17 22 5 31 19 11 7 -1 -18 -49 -18 -111
Tax % -31% 28% 29% -2% 39% 18% 32% 20% 181% -34% -9% -22% -34%
-7 12 16 5 19 16 8 6 -1 -12 -44 -14 -73
EPS in Rs -0.55 0.97 1.00 0.34 1.19 1.01 0.50 0.35 -0.09 -0.70 -2.63 -0.82 -4.34
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
314 374 431 412 325 403 548 580 600 686 789 773 815
268 315 370 344 300 395 515 517 534 605 656 738 814
Operating Profit 46 60 61 68 24 8 33 63 66 80 133 35 1
OPM % 15% 16% 14% 16% 8% 2% 6% 11% 11% 12% 17% 5% 0%
3 1 2 -1 13 9 14 21 5 19 29 17 -86
Interest 18 22 21 22 26 26 23 31 36 36 62 62 59
Depreciation 9 9 10 10 12 9 9 11 19 27 33 49 51
Profit before tax 23 29 32 35 0 -18 14 41 15 36 67 -60 -194
Tax % 34% 35% 19% 26% 809% -22% 24% 26% 45% 28% 29% -14%
15 19 26 26 -1 -14 11 31 8 26 48 -51 -142
EPS in Rs 1.57 2.01 2.69 2.66 -0.08 -1.17 0.88 2.53 0.65 1.65 3.03 -3.07 -8.49
Dividend Payout % 19% 17% 17% 17% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 8%
5 Years: 7%
3 Years: 9%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -274%
Stock Price CAGR
10 Years: 7%
5 Years: 15%
3 Years: -8%
1 Year: -6%
Return on Equity
10 Years: 3%
5 Years: 3%
3 Years: 1%
Last Year: -7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 9 9 10 10 10 12 12 12 13 16 16 17 17
Reserves 52 67 88 111 165 319 314 365 406 577 626 699 613
107 132 135 159 242 218 313 340 378 461 617 511 527
92 79 113 102 56 128 141 175 270 293 335 345 300
Total Liabilities 260 287 346 382 474 678 781 891 1,067 1,346 1,594 1,572 1,456
54 48 63 89 79 72 82 96 294 304 583 577 566
CWIP 1 2 0 1 14 20 68 198 18 207 28 31 24
Investments 1 4 5 7 44 148 69 74 74 82 82 80 64
204 234 278 285 337 438 562 523 681 753 901 884 802
Total Assets 260 287 346 382 474 678 781 891 1,067 1,346 1,594 1,572 1,456

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
13 13 26 51 -30 -5 -45 74 26 47 19 82
-10 -7 -23 -49 -31 -116 -3 -66 -88 -172 -115 -52
1 -3 -5 -1 61 120 65 -26 80 129 78 -34
Net Cash Flow 3 3 -1 0 0 -1 17 -18 18 3 -18 -4

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 80 89 105 87 148 192 174 204 224 235 243 232
Inventory Days 162 75 118 176 209 138 98 91 127 132 252 210
Days Payable 136 93 123 119 65 137 95 125 186 196 248 234
Cash Conversion Cycle 105 72 100 144 291 192 177 170 165 171 246 208
Working Capital Days 111 123 118 132 260 245 210 206 220 205 255 242
ROCE % 26% 28% 24% 24% 7% 2% 6% 11% 7% 8% 11% 0%

Shareholding Pattern

Numbers in percentages

7 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
21.71% 17.65% 17.65% 17.64% 17.64% 17.64% 16.52% 48.03% 48.03% 48.04% 48.03% 48.03%
4.81% 10.50% 10.74% 11.32% 10.94% 10.18% 10.11% 1.61% 0.99% 1.69% 1.01% 0.81%
17.88% 14.47% 14.20% 13.53% 12.53% 12.32% 9.31% 3.89% 3.75% 4.55% 4.88% 4.23%
0.00% 0.00% 0.00% 0.00% 0.00% 0.03% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00%
55.60% 57.37% 57.42% 57.52% 58.88% 59.82% 64.01% 46.46% 47.22% 45.73% 46.07% 46.93%
No. of Shareholders 56,39455,27757,83557,90454,19752,92152,27857,09862,09858,16562,68767,750

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls